Nutriband (NASDAQ:NTRB) Shares Down 0.8% – What’s Next?

Nutriband Inc. (NASDAQ:NTRB) traded down 0.8% during mid-day trading on Friday. The stock traded as low as $6.00 and last traded at $6.22. Approximately 27,919 shares were traded during mid-day trading, a decline of 78% from the average session volume of 127,966 shares. The stock had previously closed at $6.27.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Nutriband in a research report on Monday, September 28th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Nutriband has a consensus rating of “Reduce”.

Nutriband Trading Down 0.8%

The company has a market capitalization of $75.64 million, a PE ratio of -11.74 and a beta of 1.92. The stock has a fifty day moving average of $5.86 and a two-hundred day moving average of $4.28.

Nutriband (NASDAQ:NTRB) last posted its quarterly earnings results on Friday, September 4th. The company reported ($0.07) earnings per share for the quarter. Nutriband had a negative return on equity of 109.07% and a negative net margin of 430.35%. The business had revenue of $0.44 million during the quarter.

Nutriband Company Profile

Nutriband Inc (NASDAQ:NTRB) develops and manufactures transdermal patches and other wearable drug-delivery products for pharmaceutical, over-the-counter, consumer, and wellness markets. The company’s capabilities include product development, formulation, manufacturing, packaging, and private-label services for customers seeking patch-based delivery systems.

Nutriband’s portfolio includes consumer and wellness patches, as well as prescription-focused transdermal technologies. Its AVERSA platform is designed to incorporate abuse-deterrent features into transdermal products, with the goal of helping reduce the risk of drug extraction, misuse, or abuse.